https://doi.org/10.1186/s13023-022-02575-4
Y
Yanlong Duan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
101
Papers
194
Citations
8
h-index
5
i10-index
Yanlong Duan is an academic researcher from Hubei University of Medicine. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & CNS Lymphoma Diagnosis and Treatment & Lung Cancer Treatments and Mutations. The author has an h-index of 8, co-authored 86 publications.
ORCID: 0000-0003-2048-6397Papers by this author
worksA retrospective study of 18 children with subcutaneous panniculitis-like T-cell lymphoma: multidrug combination chemotherapy or immunomodulatory therapy?
2022 · Orphanet Journal of Rare Diseases · 13 citations
Impact of Methotrexate and 7‐Hydroxymethotrexate Exposure on Renal Toxicity in Pediatric Non‐Hodgkin Lymphoma
2025 · Cancer Medicine · 6 citations
https://doi.org/10.1002/cam4.70516
Inborn errors of immunity and its clinical significance in children with lymphoma in China: a single-center study
2024 · Jornal de Pediatria · 3 citations
https://doi.org/10.1016/j.jped.2024.02.002
A case series of B-Lymphoblastic lymphoma with C-MYC rearrangement in children: diagnostic and therapeutic challenges
2025 · Annals of Hematology · 1 citations
https://doi.org/10.1007/s00277-025-06330-0
Safety of low-dose radiotherapy in newly diagnosed stage I/II extranodal NK/T-cell lymphoma: a single-center retrospective analysis
2025 · Annals of Hematology · 0 citations
https://doi.org/10.1007/s00277-025-06497-6
Optimizing Diagnostic Strategies for Malignant Serous Cavity Effusion: The Role of Cytomorphological Examination Combined with High Fluorescent Cells and Total Protein
2025 · Malawi Medical Journal · 0 citations
https://doi.org/10.4314/mmj.v37i2.5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat